A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery

MLA

Sandra Robla, et al. “A Ready-to-Use Dry Powder Formulation Based on Protamine Nanocarriers for Pulmonary Drug Delivery.” European Journal of Pharmaceutical Sciences, vol. 185, June 2023, p. 106442. EBSCOhost, https://doi.org/10.1016/j.ejps.2023.106442.

APA

Sandra Robla, Rubén Varela Calviño, Rita Ambrus, & Noemi Csaba. (2023). A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery. European Journal of Pharmaceutical Sciences, 185, 106442. https://doi.org/10.1016/j.ejps.2023.106442

Chicago

Sandra Robla, Rubén Varela Calviño, Rita Ambrus, and Noemi Csaba. 2023. “A Ready-to-Use Dry Powder Formulation Based on Protamine Nanocarriers for Pulmonary Drug Delivery.” European Journal of Pharmaceutical Sciences 185 (June): 106442. doi:10.1016/j.ejps.2023.106442.